(More information) L-Carnitine is also approved for the treatment of carnitine deficiencies secondary to inherited diseases, such as propionyl-CoA carboxylase deficiency and medium chain acyl-CoA dehydrogenase deficiency, and in patients with end-stage renal disease undergoing hemodialysis
Do these in sequence not all at once, and not out of order
At least 10 domestic drugmakers, including Jiuyuan Gene, Huadong Medicine, Livzon Pharmaceutical Group and Qilu Pharmaceutical, have filed for approval, with more candidates in late-stage trials
VinciguerraMRomitiSFattouchKDe BellisAGrecoE
For instance, in a pilot phase-I clinical study by Dorr et al., three subjects were subcutaneously administered a starting dose of 0.01 mg/kg of MT-II, followed by daily injections of MT-II or placebo for two consecutive weeks
elevated blood sugar or joint pain)